Skip to Main Content

Paper Details

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.
Cancers (Basel)
0
2023
Author NameAffiliation
Michael HeuserHannover Medical School
Felicitas TholHannover Medical School
  • 1 - 2

Datasets

Release 1.2